drugset / Trial / NCT00969163
A Study to Investigate Biomarkers of Skin Androgenization Following Testosterone Administration (0000-015)(COMPLETED).
RandomizedParallel-groupDouble-blindDiagnostic
Summary
Postmenopausal women will receive testosterone gel or matching placebo gel daily. Sebum excretion rates will be measured before and after 6 weeks of treatment.
Timeline
- Start
- 2004-10
- Primary completion
- 2005-04
- Completion
- 2005-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Testosterone | Small molecule | 300 ug | Other |
| Subject | Testosterone | Small molecule | 2.5 mg | Other |
Indications
No indication recorded.